Optical coherence tomographic features of macular pathologies in diabetic retinopathy by Murali, M
OPTICAL COHERENCE  TOMOGRAPHIC FEATURES 
OF MACULAR PATHOLOGIES IN DIABETIC 
RETINOPATHY 
Dissertation submirtted to Tamil Nadu Dr.M.G.R. Medical University, Chennai
M.S.Degree Examination,   Branch III, Ophthalmology, March – 2008
1
OPTICAL COHERENCE  TOMOGRAPHIC FEATURES OF MACULAR 
PATHOLOGIES IN DIABETIC RETINOPATHY 
Dissertation submitted to
THE TAMILNADU Dr. M.G.R. MEDICAL UNIVERSITY
CHENNAI, INDIA
M.S. DEGREE EXAMINATION
BRANCH – III, OPHTHALMOLOGY
March- 2008
2
INSTITUTE OF OPHTHALMOLOGY
JOSEPH EYE HOSPITAL , TIRUCHIRAPALLI
This is to certify that the dissertation entitled  OPTICAL COHERENCE  TOMOGRAPHIC 
FEATURES OF MACULAR PATHOLOGIES IN DIABETIC RETINOPATHY is a Bonafide 
work done by Dr.M.MURALI , MS, student during May 2005 to March 2008 under our direct 
supervision and guidance at our institute in partial fulfillment of regulations governing the 
award  of  Master  of  Surgery  Branch  III  ophthalmology  Tamilnadu  Dr.MGR  MEDICAL 
UNIVERSITY CHENNAI MARCH 2008.
Dr. C.A.Nelson Jesudasan ,  MS, DOMS, FRCS( Edin and Glas)
Professor and Director
Dr. M.Rajamohan , MS, DO, CCEH (London)
Professor and HOD Retina ( Guide)
Dr. Amjad Salman, MS (ophthal)
Professor and Registrar (Co-Guide)
                                      
3
                                     ACKNOWLEDGEMENT
I  thank  Dr. C.A.  Nelson Jesudasan,  Director and Professor, Institute of Ophthalmology, 
Joseph Eye Hospital, Trichy, for his support and guidance rendered in this study.
I thank Dr. M. Rajamohan, Professor and HOD of retina, Institute of Ophthalmology, Joseph 
Eye Hospital, Trichy, Guide for his guidance, that I received in every step of this study.
I thank Dr . Amjad salman, Professor and Registrar, Institute of Ophthalmology,  Joseph 
Eye Hospital, Trichy,  co guide for his guidance ,that I received in every step of this study.
I thank Dr. Prathiba, Reader and RMO, Institute of Ophthalmology, Joseph Eye Hospital, 
Trichy. for timely help and advice given to me during this study.
I thank Dr. V. M. Loganathan, Formerly Professor and Director RIOGOH Chennai for his 
advice given to me during this study.  
I thank Mr. Rajkumar , Librarian, Mr. Venkataraman Assistant Registrar, Mr. Daniel 
Prince, Assistant Librarian for their support during the study
I thank my mother Mrs. Sarojini and my wife Mrs .Leela and my children Swathika and 
Thathika for  their prayers and moral support. I thank all my patients who participated in this 
study
4
                            CONTENTS
                                                                  
           INTRODUCTION                                                              …………         1
           AIMS AND OBJECTIVES                                                 …………         2
                                              
           REVIEW OF LITERATURE                                              …………         3
       
           MATERIALS AND METHODS                                         ………….        22
           RESULTS                                                                         ………….      27    
           DISCUSSION                                                                  …………          48
          
           SUMMARY                                                                     ………… .         51
           CONCLUSSION                                                              ………….        52 
          
           BIBLIOGRAPHY                                                             ………….         53
 
           APPENDIX                                                                        ………….       57
  
            MASTER CHART                                                      
5
___________________________________________________________________
INTRODUCTION 
___________________________________________________________________
6
INTRODUCTION
                  
High  resolution  cross  sectional  imaging  of  retina  is   useful   for 
identifying  ,monitoring  and  quantitatively  assessing  macular  disease  .  Optical 
Coherence  Tomography  (OCT)  Is  a  new medical  diagnostic  imaging  technology 
which  can  perform  high  resolutional  cross  sectional  tomographic  imaging  in 
biological tissues. Cross sectional images of retina are obtained at the resolution 10 
microns.  OCT uses  low coherence  or  white  light  interferometry  to  perform  high 
resolutional measurements and imaging. The infra red light beam has a wave length 
of 820nm
Macular  pathologies  in  diabetic  retinopathy  consists  of  1)Macular 
edema which may be  localized , diffuse , CSME and ischemic which may show on 
OCT as (a) Sponge like thickening (b) Cystoid macular edema (c) Subfoveal serous 
detachment  (d)  Taut  posterior  hyaloid  membrane  (e)  Foveal  tractional  retinal 
detachment
OCT  offers  an  objective  method  for  qualitative  identification  and 
quantitatively monitoring and evaluation of patients with diabetic maculopathy which 
are not seen clinically and by FFA 
  
                       
7
___________________________________________________________________
AIMS AND 
OBJECTIVES
___________________________________________________________________
8
AIMS OF THE STUDY
 To study the OCT features of various macular pathologies in diabetic 
retinopathy.
 To  compare  these  features  with  clinical  features  and  fundus  fluorescein    
angiographic features.
 To compare foveal thickness by OCT with visual acuity.
 To quantitatively monitoring the response by measuring the foveal thickness by 
OCT  in  various  types  of  diabetic  macular  pathologies  after  Intra  vitreal  
triamcinolone acetonide [IVTA].   
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REVIEW OF LITERATURE
ANATOMY OF MACULA [1]
Macula refers to that part of central retina having a diameter of 5.5mm 
and limited by superior and inferior temporal vascular arcades, including optic   disk 
on nasal side and histologically by outer boundary of perifovea where the ganglion 
cells are reduced to a single layer
PARTS OF THE MACULA
 UMBO it is a tiny depression in the very center of the foveola which corresponds 
to the ophthalmoscopically visible foveal reflux
 FOVEOLA  (350microns-0.35mm)  it  is  a  small  central  region  in  which  the 
thickness of retina is reduced so as to contain only photoreceptors glialcells and 
mullercells
 FOVEAL AVASCULAR ZONE(FAZ-800microns-0.8mm)it is located inside fovea 
but outside foveola
 FOVEA (1500microns-1.5mm)it is a small depression where the retina is reduced 
to half its normal thickness. Moving towards the centre of retina the inner nuclear 
layer is reduced to a double row of cells at edge of fovea
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 PARA  FOVEAL  AREA  (2500microns-2.5mm)  it  is  characterized  by  densest 
accumulation of nerve cells in the entire retina especially ganglion cells and inner 
nuclear layer. The outer boundary is the point where the ganglion cell layer has 
four rows of nuclei
 PERI  FOVEAL AREA(5500 microns-5.5mm) it  ends where  ganglion  cells  are 
reduced to a single layer
 HISTOLOGY OF MACULA: The center of  macula is the fovea containing the 
following layers; internal limiting membrane, outer plexiform layer, outer nuclear 
layer, layer of cones, and retinal pigment epithelium. 
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DIABETIC RETINOPATHY
Diabetic retinopathy is a leading cause of severe loss of visual acuity (3rd common 
cause) in the world. About 25% of diabetic patients have sight threatening levels of 
retinopathy with legal blindness. DR being 25 times more common in diabetics when 
compared to the non diabetic population (2)
ETIOPATHOGENESIS
The exact cause of diabetic microvascular disease is unknown. It is believed that 
exposure  to  chronic  hyperglycemia  results  in  a  number  of  biochemical  and 
physiological changes that ultimately causes vascular endothelial damage.
There is an association between higher levels of glycosylated hemoglobin (Hb A1c) 
and diabetic retinopathy and CSME HLA B 8, B15, DR3, DR4, is more commonly 
found more in patients with IDDM than NIDDM.
PATHOGENESIS OF MICROVASCULAR OCCLUSION (AAO-2000-2001)
1) Basement membrane thickening,2) Damage and proliferation of endothelial cells. 
3) Erythrocyte aggregation leading to defective O2 transport. 4) Increased platelet 
adhesiveness  5]  Abnormal  levels  of  growth  hormones  like  VEGF.  6)  Defective 
fibrinolysis. 7) Abnormal serum lipids. 8) Increased blood viscosity .All these leading 
to 
A) Breakdown of inner blood retinal barrier (tight junctions of capillary endothelium)
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B) Loss of pericytes leading to physical weakening of capillary wall resulting in 
localized vascular out pouching  termed micro aneurysms which may leak or 
become thrombosed  
                                                                                                                              
FEATURES OF DIABETIC RETINOPATHY
1) VENOUS CHANGES: Earliest, consists of dilatation of veins and later looping, 
beading and sausage like segmentation, FFA shows these findings
2)MICROANEURYSMS: Earliest  due to weakening of capillary walls, results in 
localized secular out pouching of vessel wall and appears as tiny round red dots 
.FFA shows hyper fluorescent dots
3) HARD EXUDATES: Due to capillary leakage and appears as waxy yellow lesions 
with  relatively  distinct  margins  often  arranged  in  clumps  or  rings  around  blood 
vessels  at  posterior  pole.  FFA  shows  hypo  fluorescence  due  to  blockade  of 
background choroidal fluorescence. OCT shows hyper reflective lesions
4) HEMORRHAGE: Intra retinal dot and blot; Arises from venous end of capillaries 
located in compact middle layers of retina .Blot hemorrhages due to hemorrhagic 
infarcts  ,Nerve  fiber  layer  flame shaped  Hemorrhage  arises  from superficial  pre 
capillary  arterioles  FFA  shows  blocked  fluorescence  (18,19).OCT  shows  in  thin 
hemorrhages  increased  scattering  and  hyper  reflective  lesions  and  thick 
hemorrhages blocks the reflections from under lying structures and appears hypo 
reflective 
5) COTTON WOOL SPOTS: They represent focal infarcts of retinal nerve fiber layer 
due to  occlusion  of  pre  capillary  arterioles  which  in  turn  leads to  interruption  of 
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axoplasmic transport with subsequent build up of transported materials within axons 
(axoplasmic stasis) and appears as white fluffy superficial  lesions with ill  defined 
borders and obscures underlying blood vessels and seen mostly in post equatorial 
retina.  FFA shows hypo florescence due to  capillary  non perfusion.  OCT shows 
hyper reflective lesions
                                                                                                                                 
6)INTRA RETINAL MICROVASCULAR ABNORMALATIES(IRMA): They represent 
shunts that run from retinal arterioles to venules bypassing capillary bed and are 
therefore   often seen adjacent to areas of capillary closure. They are seen as fine 
red lines running from arterioles to venules thus resembling focal areas of flat retinal 
new vessels but they are intra retinal location and fail to cross major blood vessels. 
FFA  shows  hyper  fluorescence  with  absence  of  leakage  adjacent  to  areas  of 
capillary closure
7) ARTERIAL CHANGES: Narrowing, obliteration and silver wiring.
8) NEOVASCULARISATION:  They are fresh endothelial  channels arising due to 
severe ischemia and appear frond like rising above retina may be associated with 
fibrous tissue which may appear over the disc or within 1disk diameter around the 
disk(NVD) or they may appear in other areas elsewhere(NVE) which may be high 
risk or low risk. FFA shows hyper fluorescence with leakage
          NVD Low risk < 1/3DD, NVD High risk >1/3DD, associated with hemorrhage
          NVE Low risk <1/2 DD, NVE High risk >1/2DD, associated with hemorrhage
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 9)  INVOLUTIONAL,  END  STAGE,  BURNT  OUT  RETINOPATHY:  Attenuated 
vessels  pale  disk,  neovascularisation  replaced  by  glial  scar  tissue,  opaque 
membranes and tractional retinal retinal detachment
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ETDRS CLASSIFICATION  OF DIABETIC RETINOPATHY (4,5)
1) NON PROLIFERATIVE DIABETIC RETINOPATHY.
        A) MILD:                    Few micro aneurysms in less than 4 quadrants
                                        Few dot hemorrhages in less than 4 quadrants
                                           Hard exudates and macular edema may or may not  
  be present                                 
   
        B) MODERATE:         Micro aneurysms or dot haemmorages present in 4 
Quadrants   
Hard exudates, Macular edema, cotton wool spots   
Venous beading and looping in 1 quadrant
        C) SEVERE (4:2:1rule): Severe intra retinal hemorrhages (dot and blot) in 4 
         Quadrant
                                                Venous beading in 2 quadrants 
         IRMA in 1 quadrant
                                               Along with microaneurysms ,hardexudates, macular 
        edema, cws 
        D) VERY SEVERE:    Any 2 of the features of NPDR
                                           
    2) PROLIFERATIVE DIABETIC RETINOPATHY: All of the above features
         with neovascularisation 
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                             DIABETIC MACULOPATHY(6,7,8,9)
Due to involvement of macula by edema and hard exudates due to 
capillary leakage or ischemia due to capillary closure and it is the most common 
cause for visual impairment in diabetic patients mostly type 2 diabetics which may 
be
 Focal exudative
 Diffuse exudative
 CSME
 Ischemic
 Mixed
FOCAL EXUDATIVE: 
Well  circumscribed retinal  thickening due to  edema associated  with  complete  or 
incomplete  rings  of  perifoveal  hard  exudates.  FFA  shows  late  focal  hyper 
fluorescence due to focal leakage with good macular perfusion .OCT shows focal 
sponge like thickening
DIFFUSE EXUDATIVE: 
Diffuse retinal edema and thickening which may be associated with cystoid changes 
with obliteration of land marks which may render localization of the fovea impossible. 
FFA shows widespread late diffuse hyperfluorescence with flower  petal  pattern if 
cystoid macular edema is present, OCT shows diffuse sponge like thickening and 
fluid filled cyst like spaces if  cystoid macular edema is present
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CLINICALLY SIGNIFICANT MACULAR EDEMA; (CSME);
  1) Retinal edema within 500 microns of centre of fovea
  2) Retinal edema of one disk diameter(1500 microns) or larger any part of which 
      is within one disk diameter of centre of fovea
  3) Hard exudates within 500 microns of centre of fovea with adjacent retinal 
edema which may be outside 500 microns
  FFA shows focal hyper fluorescence or blocked fluorescence within 500 microns of 
centre of fovea .OCT shows sponge like or cyst like spaces within 500 microns
  ISCHEMIC MACULOPATHY: Due to macular non perfusion with decreased visual 
acuity with relatively normal appearance of  fovea . Dark blot haemmorages may be 
seen .FFA shows capillary non perfusion areas at the fovea and enlargement of 
foveal avascular zone (FAZ)
  MIXED EXUDATIVE AND ISCHEMIC: Signs characterized by features of both 
ischemic and exudative maculopathy
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Optical Coherence Tomography
Optical  Coherence  Tomography  is  a  new  diagnostic  tool  that  can  perform 
tomography / cross – sectional imaging of biological tissues with ≤10 microns axial 
resolution using light waves.
Principle:
  
It uses infrared light. The speed of light is almost a million times faster than sound 
and this difference allows the measurement of  structures with  resolution of  ≤ 10 
microns compared to 100 micron scale of ultrasound. Ultrasound needs contact with 
the tissue under study, whereas OCT does not, require any contact.
It is a non contact, non – invasive device where a broad band width of near infra – 
red light beam (820nm) is projected on to the retina. The light gets reflected from the 
boundaries  between  the  microstructure  and  also  gets  scattered  differently  from 
tissues with different optical properties. It then compares the echo time delay of the 
same wavelength that is reflected from a reference mirror at a known distance.
Optical coherence tomography uses, low coherence or white light interferometry to 
perform high resolution measurements and imaging.
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An optical beam from a laser or light source which emits short optical pulses or short 
coherence length light,  is  directed onto a partially  reflecting mirror  (optical  beam 
splitter). The partially reflecting mirror splits the light into two beams, one beam is 
reflected and the other is transmitted. One light beam is directed on to the patients 
eye and is reflected from intraocular structures at different distances.
The reflected light beam from the patient’s eye consists of multiple echoes which 
give information about the range or distance and thickness of different intra-ocular 
structures. The second beam is reflected from a reference mirror at a known spatial 
position. This retro-reflected reference optical beam travels, back to the partial mirror 
(beam splitter) where it combines into the optical beam reflected from the patient’s 
eye.
When  the  two  light  pulses  co  inside  they  produce  a  phenomenon  known  as 
interference which is measured by a light sensitive detector (photodetector). Thus 
the interferometer can precisely measure the echo structure of reflected light and 
perform high resolution measurements of  the distance and thickness of  different 
tissue structures.
The key feature of interferometer is that it can measure the time delay of optical 
echoes by comparing the reflected light  beam with  a reference beam. While the 
explanation  presented  here  assumes that  the  light  is  composed of  short  optical 
pulses, the measurement may also be performed using non-pulsed or continuous 
light with a short coherence length. For this reason, the measurement techniques 
has been termed ‘low coherence interferometry’.
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The light source for the interferometer is a compact super luminescent diode, which 
is coupled directly into an optical fiber. This light source is similar to laser diode used 
in optical compact disc players, except in OCT, the diode source is designed to emit 
short coherence length light. The interferometer is constructed using a fiber optic 
coupler which functions, analogous to a beam splitter. The arm of the interferometer 
which consists of reference mirror is located within the instrument, while the optical 
fiber in the second arm of the interferometer is connected to the OCT ophthalmic 
instrument resembling a slit lamp biomicroscope or fundus camera.
Image resolution
The  image  resolution  of  OCT  in  the  axial  (or  longitudinal)  verses  transverse 
directions is determined by different mechanisms. The resolution of the image in the 
axial (longitudinal) direction is determined by the resolution of the optical ranging 
measurement. This is determined by the physical properties of light source which is 
used for the measurement. If a short pulse laser source is used, the axial resolution 
is determined by the pulse duration. Conversely, if a continuous, low-coherence light 
source is used, the axial resolution is determined by the ‘coherence length’ of the 
light  source.  It  is  important  to  note that  the  measurement  of  distance or  tissue 
thickness can, in practice, be performed with significantly higher resolution than this 
limit. 
The transverse resolution of the image is determined by the size of the focused 
optical beam. This is a function of the optics used to project the beam onto the eye 
and this is determined by factors such as whether imaging is performed over a large 
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depth, such as in the anterior eye, or whether the focusing angle is restricted, as in 
imaging  the  retina.  The  image  resolution  is  also  a  function  of  the  size  of  the 
tomogram that is desired.
OCT Scan Protocols in Macula
The protocols that are helpful in macular diseases are the following.;
(i) Line Scan
The line scan gives an option of acquiring multiple line scan without returning to 
main window. The length of the line scan and the angle can be altered, though one 
has to keep in mind that as the scan length increases the resolution decreases.
(ii) Radial Lines
The scan protocol consists of 6 -24 equally spaced line scans that can be varied in 
size and parameters. All the lines pass through a central common axis. The radial 
lines are useful for acquiring macular scan and retinal thickness / volume analysis.
(iii) Macular thickness map
This is the same as radial lines except that the aiming circle has a fixed, diameter of 
6mm. This helps in measuring the retinal thickness.
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(iv) Fast macular thickness map
It is designed for use with retinal thickness analysis. When done in both the eyes, it 
can be used for comparative retinal thickness / volume analysis. It is a quick protocol 
that takes only 1.95 sec to acquire six scans of 6mm length each
(v) Raster Line
This provides an option of acquiring series of line scans that are parallel, equally 
spaced and are  6 –  24  in  number.  These multiple  lines  scans are  placed over 
rectangular regions, the area of which can be adjusted so as to cover the entire area 
of  pathology.  This  is  especially  useful  in  conditions  like  choroidal  neovascular 
membrane one wishes to obtain scans at multiple levels.
(vi) Repeat:
Repeat protocol enables one to repeat any of the previously saved protocols using 
same set of parameters, that includes scan size, angle, placement of fixation, light 
emitting diode (LED) and landmark.
Normal macular scan
On a 10mm horizontal line scan passing through the foveal centre, one can clearly 
demarcate two major landmarks namely optic disc and fovea.
The optic disc is seen towards the right of the tomogram and is easily identifiable by 
its  contour.  The central  depression  represents  the  optic  head cup and the  stalk 
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continuing behind is the anterior part of the optic nerve. The fovea is seen to the left 
and is easily identifiable by the characteristic thinning of retinal layers. The vitreous 
anterior to the retina is non-reflective and is seen as a dark space. The interface 
between  the  non  –  reflective  vitreous  and  back  scattering  retinal  layers  is  the 
vitreoretinal  interface.  The retinal  nerve  fiber  layer  (NFL)  is  highly  reflective  and 
increases in thickness towards the optic nerve. The posterior boundary of the retina 
is marked by a hyper – reflective layer that represents retinal pigment epithelium 
(RPF) and chorio capillaries.
Just anterior to RPE – choriocapillaries complex, is a minimally reflective layer that 
represent photoreceptors. Above this layer of photoreceptors are alternating layers 
of  moderate  and  low reflectivity  that  represents  different  layers  of  neurosensory 
retina. The retinal blood vessels within the neurosensory retina shows back scatter 
and also cast a shadow behind.
Image Interpretation:
a) Objective
b) Subjective
1) Objective
Hyper – reflective lesions are:
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Hard exudates:  are seen as hyper – reflective shadows in the neurosensory retina 
that completely blocks the reflections from the underlying retina.
Blood:  Blood causes increasing scattering. Small to thin hemorrhages are seen as 
hyper  reflective  lesions  .Thick  hemorrhages  blocks  the  reflections  from  the 
underlying structure.
Scars : All fibrotic lesions including disciform scars, choroidal rupture scars, healed 
choroiditis etc are hyper – reflective.
Hypo – reflective lesions are:
Serous fluid:  Retinal edema is the commonest cause of reduced back scattering 
and one can actually point out the site of fluid accumulation. The serous fluid that is 
devoid of  any particular matter,  produces an optically empty space with  no back 
scattering.
Hypo – pigmented lesions of RPE.
Subjective analysis.
Qualitative,
Protocols are a) Normalize
b) Align
c) Median Smoothing
d) Gaussian Smoothing
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Quantitative:
a) Retinal thickness / volume
b) Retinal thickness or volume tabular 
c) Retinal thickness / volume change
Advantages of OCT over FFA
• Non contract, non invasive
• Time saving technique
• Totally avoids mild complications like nausea to life threatening hypersensitivity 
reactions seen in FFA.
• Measurement of  retinal  thickness by OCT correlate  more strongly  with  visual 
acuity than the presence of leakage on angiography.
• OCT is effective and superior to FFA in demonstrating axial distribution of fluid.
• Can be repeated as many times needed.
• Can quantitatively assess retinal thickness and demonstrate any associated RPE 
structural anomalies.
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OCT : Features in Diabetic maculopathy (10)
OCT almost gives the in vivo histopathology of retinal layers that help in the better 
disease understanding and pathogenesis. Oct is a useful tool in monitoring response 
to  an  intervention  (IVTA)  in  maculopathy.  There  are  five  patterns  of  diabetic 
maculopathy. They are.
1. Sponge like thickening of retinal layers : This is mostly confined to outer retinal 
layers and reduced back scattering from intra retinal fluid accumulation.
2. Cystoid macular edema : Large cystoid spaces involving variable depth of retina 
with intervening septae. The cystoid spaces are initially confined to outer retina 
mostly  but  in  long  standing  cases  these  cysts  fuse  to  involve  almost  entire 
thickness of retina.
3. Subfoveal serous detachment; This is shown as hypo reflective area in subfoveal 
region
4. Taut posterior hyaloid membrane; This may result in recalcitrant macular edema 
with foveal detachment that can be diagnosed easily on OCT even when sub 
clinical.  In  advanced  cases  it  can  be  diagnosed  as  a  taut  shiny  glistening 
membrane with retinal striae on bio microscopic examination. CSME with TPHM 
is generally non responsive to laser and is an indication for Pars plana vitrectomy
5. Tractional detachment of fovea; Foveovitreal traction may result in detachment of 
fovea, This can be diagnosed easily in OCT. This is an indication for pars plana 
vitrectomy to  release  the  traction.  Laser  photo  coagulation  may only  worsen 
macular edema.
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MATERIALS AND METHODS
Patients  with  diabetic  maculopathy  who  presented  to  the  Retina  Clinic  of 
Institute of Ophthalmology Joseph Eye Hospital Trichy between July 1st 2006 to June 
30th 2007 are included in this study
PATIENTS: Sixty three eyes of forty patients with diabetic retinopathy
INCLUSION CRITERIA:
All patients with clinical diagnosis of diabetic maculopathy whether NPDR or 
PDR
EXCLUSIONCRITERIA: 
Patients  with diabetic retinopathy NPDR or PDR with out maculopathy
Patients with other causes of maculopathy
METHODS:
A standard protocol was used to collect and document all details regarding 
the cases included in this study
A detailed information about the history of diabetes, with duration and associated 
risk factors like Hypertension, Nephropathy, and Cardiovascular disease was taken
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The history of treatment of diabetes, whether oral hypoglycemic drugs or insulin 
was taken
Visual acuity, Distance vision, Near vision, Best corrected visual acuity was taken 
initially and after intra vitreal triamcinolone acetonide at 1, 2, 3, 6 months follow up
A complete ocular examination was done for each patient which included slit lamp 
examination  of  anterior  segment,  90D  slit  lamp  indirect  ophthalmosocpic 
examination,  indirect  ophthalmoscopic  examination,  and  following  were  noted 
clinically
1) Type of diabetic retinopathy; NPDR or PDR
2) Type of maculopathy; Focal, Diffuse, CSME, CME , foveal tract ional RD were 
noted
A fundus photograph was taken to document clinical findings
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A digital fundus fluorescein angiography was done using Carl Zeiss ff450 plus IR 
digital camera. 3ml of 20% sodium fluorescein  is injected into anterior cubital vein. A 
series of photographs are taken. Normally fluorescein begins to show in the choroid 
in10  to12  seconds  after  injection.   The  type  of  leaks  and  area  of  leak  (hyper 
fluorescence) whether focal, or diffuse or specific  pettaloid pattern is taken. A note 
was made on macular perfusion , late staining and blocked fluorescence due to hard 
exudates
Optical coherence tomography was done using Carl Zeiss stratus OCT 3. Fast 
macular scan was done at the time of presentation .This protocol is designed for use 
with retinal thickness analysis in all cases. It is a quick protocol that takes only 1.92 
seconds to acquire 6 scans of 6mm length each and various parameters noted for 
presence of maculopathy, The type of maculopathy, CME, Sponge like thickening, 
Subfoveal serous detachment, Taut posterior hyaloid membrane and Vitreo macular 
tract ional RD was noted
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TREATMENT
         Patients  who  had  CME,  Sponge like  thickening  and  subfoveal  serous 
detachment was given intra vitreal triamcinolone acetonide injection of 0.1ml (4mg) 
and immediate  post intervention the patients was given tab Diamox 250mg tds for 2 
days, Timolol eye drops 0.5% bd for 2 weeks, ciprofloxacin eye drops 0.03% for 2 
days
FOLLOW UP
The patients were followed up at 1 week, 1 month, 3months,and 6 months and all 
patients who under went IVTA underwent OCT examination and foveal thickness 
measurement at 6 months follow up and  IOP recorded at each visit.
 STATISTICAL ANALYSIS  
         Statistical  analysis  was  done  by  student  t  test,  regression  analysis,  chi 
square test and p value < 0.05 was considered significant  
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Fig 2 
Carl Zeiss Digital Digital Camera with Fundus Fluorescein Angiogram
Fig 3
Carl Zeiss Stratus Optical Coherence Tomogram Model 3000
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RESULTS
In  this  prospective  comparative  case  series  study  63  eyes  of  40  patients  with 
diabetic maculopathy who presented at retina clinic of Institute of Ophthalmology 
Joseph Eye Hospital Trichy between July 1st 2006 to June 30th 2007 was included in 
this study
GENDER : In this study there were 28 male (70%) and 12 female (30%)
AGE :   In this study the mean age was 57.75 years(range 35 to 70 years)  and 
Maximum number of patients were in 51 to 60 yrs range 21 patients (52.7%), and 61 
to 70 yrs 14 patients (35%) , and 41 to 50 yrs 2 patients (5%) ,and 31 to 40 yrs 3 
patients (7.5%)
TYPE OF DIABETES MELLITUS; In this study there were 37 patients with NIDDM 
(92.5%),and 3 patients with IDDM (7.5%).
DURATION OF DIABETES MELLITUS: In this study duration of diabetes was 10 to 
15 years in 28 patients (70%), and 5 to 10 yrs in 6 patients (15%), and less than 5 
years in 6 patients (15%).
ASSOCIATION  WITH  SYSTEMIC  DISEASES: In  this  study   Hypertension  was 
associated with diabetes in 5 patients, and Nephropathy in 1 patient
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TYPE  OF  DIABETIC  RETINOPATHY;  In  this  study  NPDR  was  present  in  26 
patients (65%) ,PDR in 14 patients (35%).
TYPE  OF  DIABETIC  MACULOPATHY  CLINICALLY;  In  this  study  Clinically 
Significant Macular Edema was seen In 58 eyes (92%) , Cystoid Macular edema in 2 
eyes3.(2%),Diffuse Edema in 2 eyes(3.2%), Fibrous traction in1eye(1.6%)
TYPE OF DIABETIC MACULOPATHY WITH FFA: In this study With FFA, Diffuse 
leak  was seen in 49 eyes (78%), Focal leaks  in 7 eyes (11%), Pettaloid pattern in 3 
eyes (5%), Ischemic pattern in 3 eyes (5%), Blocked fluorescence in 1eye (2%).
TYPE OF DIABETIC MACULOPATHY WITH OCT: In this study with OCT, Cystoid 
macular edema was seen in 32eyes (51%), Sponge like thickening in21eyes (33%), 
Subfoveal serous detachment  in 9 eyes (14%) ,Foveal tract ional retinal detachment 
in 1 eye (2%).
 CORRELATION  BETWEEN  FOVEAL  THICKNESS  AND  VISUAL  ACUITY  IN 
DIABETIC MACULOPATHY; In this study there was no correlation between visual 
acuity and foveal thickness measured by OCT 
      In GRADE 1 visual acuity 6/6 to 6/18 There  were 6 eyes (10%)  in 400 to 500 
microns thickness
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     In  GRADE 2 VA 6/24 to 6/60 There were 15 eyes (24%) are in 300 to 400 
microns thickness
     In  GRADE 3 VA < 6/60 There were 8 eyes(13%) in 300 to 400 micron thickness
IMPROVEMENT  OF  VISUAL  ACUITY  AFTER  IVTA  IN  DIABETIC 
MACULOPATHY; In this study there was a definite increase in visual acuity after 
intravitreal triamcinolone acetonide after three months. 
CME group showed more definite increase in visual acuity than other two groups.
The  Pretreatment  mean  visual  acuity  in  decimals  was  0.2  (standard 
deviation=+/-0.16 and Post treatment mean visual acuity in decimals was 0.25(std 
dev=+/-0.16). and Visual acuity improved in 27 eyes and did not improve in 5 eyes 
paired “t” test(p value=0.009) which is statistically  significant.
SPONGE  LIKE  THICKENING  group  showed  increase  in  visual  acuity  than 
Subfoveal group but less than CME group
The  Pretreatment  mean  visual  acuity  in  decimals  was  0.16(standard 
deviation=+/-0.14) and Post treatment mean visual acuity in decimals was 0.18(std 
dev=+/-0.16) and Visual acuity improved in 14 eyes and did not improve in 7 eyes 
paired “t” test(p value=0.25) statistically not significant
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SUBFOVEAL  SEROUS  DETACHMENT  group  showed  insignificant  increase  in 
visual acuity than above two groups
The Pretreatment mean visual acuity in decimals was 0.20(std dev=+/-0.14) and
Post treatment mean visual acuity in decimals was 0.23(std dev=+/-0.16) and Visual 
acuity  improved  only  in  5  eyes  and did  not  improve  in  4  eyes  paired  “t”  test(p 
value=0.57) statistically very insignificant
IMPROVEMENT  (DECREASE)  OF  FOVEAL  THICKNESS  AFTER  IVTA  IN 
DIABETIC MACULOPATHY:  In this study there was a definite decrease in foveal 
thickness after intra vitreal triamcinolone acetonide after three months.
CME group showed more definite decrease  in foveal thickness
 The Pretreatment mean foveal thickness in microns was 452(std dev=+/-173) and 
Post treatment mean foveal thickness in microns was 273(std dev=+/-76) and the 
Thickness  reduced  in  31  eyes  and  was  not  reduced  in  1  eye  paired  “t”  test(p 
value=<0.001) statistically very significant
SPONGE LIKE THICKENING group also showed more definite decrease in foveal 
thickness
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The  Pretreatment  mean foveal thickness in microns was 464(std dev=+/-102) and 
Post treatment mean foveal thickness in microns was 282(std dev=+/-50.55)
and the Thickness reduced in all 21 eyes paired “t” test (p value=<0.001) statistically 
very significant
SUBFOVEAL SEROUS DETACHMENT group showed  only  a  slight  reduction  in 
foveal thickness 
The  Pretreatment mean foveal thickness in microns was 404(std dev=+/-96 and
Post treatment mean foveal thickness in microns was 344(std dev=+/-192) and the 
Thickness  reduced in  6  eyes  and was  not  reduced in  3  eyes  paired  “t”  test  (p 
value=0.43) statistically very insignificant 
COMPARISION OF VISUAL  ACUITY IMPROVEMENT AFTER IVTA BETWEEN 
THREE GROUPS OF DIABETIC MACULOPATHY: (Chi square test)
 In this study CME group showed more improvement in visual acuity than Sponge 
like  thickening  group  (p=0.13)  and  Sub  foveal  group  (p=0.06).And  Sponge  like 
thickening showed more improvement than Sub foveal group(p=0.55)
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COMPARISION OF FOVEAL THICKNESS REDUCTION AFTER IVTA BETWEEN 
THREE GROUPS OF DIABETIC MACULOPATHY (Chi square test) 
In this study CME group and Sponge like thickening both showed more reduction in 
foveal thickness (p=0.55)
 The CME group showed more significant reduction in foveal thickness than Sub 
foveal group (p=0.007) and Sponge like thickening group more significant reduction 
in foveal thickness than Sub foveal group (p=0.006).
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RESULTS
GENDER
SEX MALE FEMALE
NUMBER OF EYES 28 12
PERCENTAGE 70% 30%
AGE DISTRIBUTION
AGE 31 TO40 41 TO50 51 TO 60 61 TO 70
NO PATIENTS 3 2 21 14
PERCENTAGE 7.5% 5% 52.5% 35%
TYPE OF DIABETES
TYPE OF DM IDDM NIDDM
NO OF PATIENTS 3 37
PERCENTAGE 7.5% 92.5%
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DURATION OF DIABETES
DURATION < 5 YEARS 5 TO 10 YEARS 10 TO 15 YEARS
NO OF 
PATIENTS
6 6 28
PERCANTAGE 15% 15% 70%
TYPE OF DIABETIC RETINOPATHY
TYPE OF DR PDR NPDR
NUMBER OF EYES 14 26
PERCENTAGE 35% 65%
TYPE OF DIABETIC MACULOPATHY CLINICALLY
TYPE OF 
MACULOPATHY
CSME CME
DIFFUSE 
EDEMA
FIBROUS 
PROLIFERATION
NO OF EYES 58 2 2 1
PERCENTAGE 92% 3.2% 3.2% 1.6%
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TYPE OF DIABETIC MACULOPATHY WITH FFA
TYPE DIFFUSE LEAK
PETTALOID 
PATTERN
FOCAL 
LEAKS
NON 
PERFUSION
BLOCKED 
FLUORESCENCE
NO  OF 
EYES 49 3 7 3 1
PERCENT 77.8% 4.8% 11.2% 4.8% 1.6%
TYPE OF DIABETIC MACULOPATHY BY OCT
TYPE
CYSTOID 
MACULAR 
EDEMA
SPONGE LIKE 
THICKENING
SUBFOVEAL 
SEROUS 
DETACHMENT
FOVEAL 
TRACTIONAL 
DETACHMENT
NO OF EYES 32 21 9 1
PERCENTAGE 50.8% 33.3% 13.8% 1.6 %
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Fig-1 OCT Picture shows Sponge like thickening of macula
fig-2 OCT Picture shows cystoid macular edema
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fig -3 Sub foveal serous detachment
fig -4 Foveal tractional retinal detachment
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OCT Picture shows cystoid macular edema
 after 6 Months post IVTA 
OCT Picture shows Sponge like thickening of macula
after 6 Months post IVTA
Sub foveal serous detachment after 6 Months post IVTA
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fig-8 Fundus picture shows NPDR
fig -9 fundus picture shows PDR with Fibrous traction
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fig-10 PDR with Foveal tract ional retinal detachment
fig-11 NPDR with CSME
54
fig –12  PDR with CSME   
55
fig-13  FFA shows cystoid macular edema(flower petal pattern) 
fig-14  FFA shows PDR with ischemic areas
56
fig-15 FFA shows PDR   with  diffuse leak. 
fig-16 FFA shows NPDR with focal leaks
57
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DISCUSSION
Optical  coherence  tomography  is  a  novel,  objective  test  for  the  qualitative  and 
quantitative evaluation of  patients with  diabetic maculopathy who may not  be so 
precisely evaluated clinically and by fundus fluorescein angiographically   
In this study 63 eyes of 40 patients were examined clinically, by FFA and by 
OCT .  On comparison between them ,OCT precisely  delineated more types 
of maculopathy than clinically and by FFA and so OCT is a more sensitive 
method of diagnosis in diabetic maculopathy.
This  is  similar  to  the  study  conducted  by  David  J   Browing  et  al  (11,12) 
(Ophthalmology,2004. AJO 2005) in which they Showed 4 abnormalities (1) 
increased  total  macular  volume  (2)  increased  foveal  zone  thickness  (3) 
increased inner parafoveal zone thickness and (4) increased outer parafoveal 
zone  thickness.   And  so  the  diagnosis  of  diabetic  macular  edema  by 
stereoscopic slit lamp biomicroscopic examination of fundus with diagnosis by 
OCT showed slit lamp diagnosis of DME is less sensitive than OCT.
 In this study on comparison between FFA findings and OCT findings, OCT 
showed more types of maculopathy and so OCT is a useful tool to diagnose 
the type of maculopathy and as an adjuvant to FFA.
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This is similar to the study conducted by SE WOONG KANG et al (13)(AJO 
FEB 2004) in which 145 eyes of 91 patients were categorized  by FFA into 3 
types ,focal leakage type ,diffuse leakage type, cystoid leakage type and by 
OCT into  4  types,  Type  1-thickening  with  homogenous  optical  reflectivity, 
Type 2-thickening with markedly decreased optical reflectivity in outer retinal 
layer,  Type  3a-foveolar   detachment  with  out   traction,  Type  3b-  foveolar 
detachment with traction and showed  (a) The prevalence of  OCT type 1 was 
higher in focal leakage type and diffuse leakage type than in cystoid leakage 
type (b) The prevalence of OCT type 2 and 3a was higher in cystoid leakage 
type than in focal and diffuse leakage type and they concluded that there was 
a correlation between features of FFA and OCT
 In this study there is no correlation between foveal thickness by OCT and visual 
acuity.
 In this study there is a definite increase in visual acuity  after IVTA in all  three 
groups but was statistically more significant in eyes with CME group. 
In this study there is a significant reduction in foveal thickness after treatment with 
IVTA for diabetic macular edema.
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The  above  three  results  are  similar  to  the  study  conducted  by  JORGEN 
LARSSON  et al (14) AJO  APRIL  2005 in which they showed that 24 eyes with 
diabetic macular edema treated by IVTA  had reduction in foveal  thickness from 
mean of 462 +/-  154 microns to 257 +/- 114 microns ( p value < 0.0001)after  3 
months  and the log MAR average visual acuity increased from 60.5+/-10.5 to 65.5 
+/-11.1 (p value =0.0001) 3 months after IVTA treatment.
  
In this study eyes with CME group showed more improvement in visual acuity after 
IVTA than Sponge like thickening group and Sub foveal serous detachment   group 
showed very little improvement  
 In this study eyes with both CME group and Sponge like thickening group 
showed significant reduction in foveal  thickness after IVTA.  Sub foveal serous 
detachment group showed very little reduction in foveal thickness after IVTA. 
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SUMMARY
In this prospective comparative  study 63 eyes of 40 patients  with Diabetic 
maculopathy were included. All  underwent examination clinically,  by FFA, and by 
OCT.   Optical  coherence  tomography  precisely  showed  four  types  of  diabetic 
maculopathy (a) Cystoid macular edema 32 eyes (b) Sponge like thickening 21 eyes 
(c) Subfoveal serous detachment 9 eyes (d) Foveal tract ional retinal detachment 1 
eye, which were not seen clinically and by FFA.
The  foveal thickness was measured by OCT in all patients at presentation 
and intravitreal triamcinolone acetonide is given to 62 eyes (except one eye  with 
vitreo macular traction for which the treatment is mainly surgical) and after 6 months 
foveal thickness measured by OCT. The foveal thickness in diabetic macular edema 
reduced  after  intravitreal  triamcinolone  acetonide.  More  significantly  in  Cystoid 
macular edema group and Sponge like thickening group than in subfoveal serous 
detachment group. 
There is no correlation between foveal thickness and visual acuity. But there 
is a increase in visual acuity after treatment with intravitreal triamcinolone acetonide. 
More significantly in Cystoid macular edema group.
OCT with  its  high  resolution  imaging  of  retina  has  a  role  in  diagnosis  of 
different types of diabetic maculopathy and to monitor the thickness of fovea before 
and after treatment with intra vitreal triamcinolone acetonide.    
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                                            CONCLUSION
Optical Coherence Tomography a non contact, non invasive investigation is 
slowly emerging as an important diagnostic tool in differentiating various types of 
diabetic maculopathy. In comparison with clinical assessment and FFA it is definitely 
turning out to be a superior and more useful method of evaluating and monitoring 
Diabetic Maculopathy either as a single procedure and may be more useful when 
used in conjunction with fundus fluorescein angiography.   
OCT is a useful tool to quantitatively monitor the response of different diabetic 
macular pathologies to intra vitreal triamcinolone acetonide by measuring the pre 
treatment  foveal  thickness  and  post  treatment  foveal  thickness  and  there  is  a 
significant reduction in foveal thickness after intra vitreal triamcinolone acetonide.
There is no correlation between thickness of fovea measured  by OCT and 
visual acuity.
Option for surgical intervention in cases of Diabetic Maculopathy with macular 
traction and taut posterior hyaloid membrane depends mainly on the OCT images 
which will clearly delineate accurately. 
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PROFORMA
         Institute of Ophthalmology, Joseph Eye Hospital, Trichy.
                                       OCT IN DIABETIC MACULOPATHY
                                                         
Study No MRD No Retina No
Name AGE Sex
Systemic diseases IHD/HT/Nephropathy/Other
s
Diabetic    Type 1 IDDM Type 2  NIDDM Duration
Treatment undergone Diet and Exercise/Drugs Insulin
VISUAL ACUITY
Distant vision 
unaided
With correction BC DVA
Right eye
Left eye
Near vision 
unaided
With correction BC NVA
RE
LE
SLIT LAMP EXAMINATION
Anterior segment Right eye Left eye
Cornea
Iris
Pupil
Lens
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FUNDUS EXAMINATION 
       (Indirect/90D)                 RE                                                  LE
Diagnosis ; NPDR ;Mild/Moderate/Severe ;PDR ;MACULOPATHY ;Focal/Diffuse
FFA                                       RE                                                  LE
OCT
SET UP
Size Site Length Width Height
MACULOPATHY(OCT)
  
1)SPONGE LIKE THICKENING
2)CYSTOID MACULAR EDEMA
3)SUBFOVEAL SEROUS DETACHMENT
4)TAUT POSTERIOR HYALOIDAL MEMBRANE
5)FOVEAL TRACTIONAL RETINAL DETACHMENT(Vitreo Retinal Traction)
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